Related Experiment Video
Updated: May 20, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
[Is hypertriglyceridaemia a risk factor for coronary heart disease?]
Zeljko Reiner1, Diana Muacević-Katanec, Davor Katanec
1Zavod za bolesti metabolizma, Klinika za unutrasnje bolesti Medicinskog fakulteta Sveucilista u Zagrebu, KBC Zagreb. zreiner@kbc-zagreb.hr
Lijecnicki Vjesnik
|July 10, 2012
Summary
High triglycerides are a significant risk factor for coronary heart disease (CHD). Lifestyle changes and medications like fibrates, niacin, and omega-3 fatty acids can effectively manage hypertriglyceridaemia.
Area of Science:
- Cardiology
- Metabolic Disorders
- Lipidology
Context:
- Elevated serum triglycerides are a key risk factor for coronary heart disease (CHD).
- Hypertriglyceridaemia often co-exists with low HDL cholesterol, particularly in patients with type 2 diabetes or metabolic syndrome, a condition known as atherogenic dyslipidaemia.
- Atherogenic dyslipidaemia is increasingly prevalent, necessitating effective management strategies.
Purpose:
- To outline the significance of hypertriglyceridaemia as a risk factor for CHD.
- To discuss the primary treatment strategies for hypertriglyceridaemia, focusing on lifestyle modifications and pharmacological interventions.
- To provide recommendations for combination therapy when LDL cholesterol is also elevated.
Summary:
- Lifestyle changes, including weight reduction, reduced alcohol and sugar intake, and aerobic exercise, can decrease triglyceride levels by up to 50%.
- For high-risk individuals unresponsive to lifestyle changes, pharmacological treatments such as fibrates, niacin, and prescription omega-3 fatty acids are indicated.
- Combination therapy, particularly statins with fenofibrate and/or omega-3 fatty acids, is recommended for patients with both elevated triglycerides and LDL cholesterol.
Impact:
- Effective management of hypertriglyceridaemia can reduce the risk of coronary heart disease in high-risk populations.
- Addressing atherogenic dyslipidaemia through lifestyle and pharmacological interventions can improve cardiovascular outcomes.
- Personalized treatment approaches, including combination therapy, are crucial for managing complex lipid profiles and mitigating CHD risk.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...